Company news

PYC Therapeutics Limited news in 2019

PYC Therapeutics Limited's news releases, calls and decks from 2019, newest first.

View company

Drug Delivery Greater Than 100% More Effective In Animals

December 1, 2019

Conclusion of Genentech Antimicrobial Collaboration

November 14, 2019

Retail Offer Document

November 3, 2019

PYCs Institutional Entitlement Offer Closes

November 3, 2019

Entitlement Offer - Investor Presentation

October 31, 2019

$26.8m Fully Underwritten Accelerated Entitlement Offer

October 30, 2019

Sept 2019 Quarterly Shareholder Update and Appendix 4C

October 30, 2019

Successful Major Milestone - Human Retina in a Dish Models

October 8, 2019

Strategic Partnership and Lead Program

October 1, 2019

Successful Time-Course Studies in Animals

September 25, 2019

Successful Competitive Drug Evaluation in Animals

September 2, 2019

Successful Time - Course Studies in Animals

August 22, 2019

Response to ASX Aware Query

August 7, 2019

Phylogicas Technology is Effective in Human Cells

August 6, 2019

Company Presentation - July 2019

July 23, 2019

Operational Update and Appendix 4C

July 23, 2019

Animal Models - 400% Outperformance of Gold Standard

July 22, 2019

Break Through Animal Model Results

June 26, 2019

March 2019 Quarterly Operational Update and App4C

April 29, 2019

Collaboration Agreement - siRNA delivery

March 13, 2019

Flagship Program - Successful Animal Models

March 11, 2019

First Competitive Read Out - Peptide Vaccine

February 8, 2019

Dec 2018 Operational Update and App4C

January 31, 2019

CEO letter and Operational Update

January 16, 2019

Decks in 2019